Skip to main content

Want a detailed portfolio tracker?

Performance analysis of BioRestorative Therapies (BRTX)

Annual Return

Over the past 3 years, BRTX has had an average annual return of +0%, underperforming the benchmark SPY, which returned +19.31% annual.

Over the past 5 years, BRTX has had an average annual return of -29.87%, underperforming the benchmark SPY, which returned +12.55% annual.

Over the past 10 years, BRTX has had an average annual return of -65.70%, underperforming the benchmark SPY, which returned +14.95% annual.

Since May 14, 2013, BRTX has had an average annual return of -59.64%, underperforming the benchmark SPY, which returned +14% annual.

20232022202120202019201820172016201520142013
+0%+0%-66.67%+0%-99.34%-75.66%+12.12%-22.32%-52.78%-10.90%-48.99%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2023+0%+0%+0%+0%+0%
2022+0%+0%+0%+0%+0%+0%+0%
2021+66.67%+60%-25.00%-16.67%+0%-40.00%-33.33%+0%+0%+0%-50.00%+0%-66.67%
2020-66.67%+0%+1,600%-52.94%+112.50%-58.82%-57.14%+0%
2019-24.40%+0.58%+15.32%-27.82%-38.54%+3.39%-16.94%-3.95%-23.97%-31.53%-72.37%-85.71%-99.34%
2018-13.54%-2.48%+1.90%-5.67%-32.01%-8.35%+19.28%-11.63%-11.16%-34.28%-30.81%+13.18%-75.66%
2017+28.73%-1.16%+1.18%+5.92%-20.02%-16.67%+8.32%+4.33%-4.15%+7.74%-10.01%+17.47%+12.12%

Drawdown analysis of BioRestorative Therapies (BRTX)

The maximum drawdown for the BRTX was -99.99%, occurring on Jan 21, 2020. This drawdown has not yet recovered.

The current BRTX drawdown is -99.99%.

Since May 14, 2013 BRTX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Jun 18, 20131659Jan 21, 2020OngoingOngoingOngoing
-17.00%May 21, 20139Jun 4, 20139Jun 17, 201318